Volume 15, Issue 3 (June 2021)                   Qom Univ Med Sci J 2021, 15(3): 210-221 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Eshaghi E, Shahvaroughi farahani A, Mousaei S, Khalifeh-Gholi M, Adnani Sadati J, Fateh R. Detecting Efflux Pumps Genes in the Fluoroquinolones Resistant and Sensitive Strains of Escherichia coli in Patients with Urinary Tract Infection in Qom, Iran. Qom Univ Med Sci J 2021; 15 (3) :210-221
URL: http://journal.muq.ac.ir/article-1-3000-en.html
1- Department of Biology, Nour Danesh Institute of Higher Education, Meymeh, Isfahan, Iran.
2- Department of Biology, Islamic Azad University Qom Branch, Qom, Iran.
3- Cellular & Molecular Research Center, Qom University of Medical Sciences, Qom, Iran
4- Department of Microbiology & Immunology, Faculty of Medicine, Qom University of Medical Sciences, Qom, Iran.
5- Department of Microbiology & Immunology, Faculty of Medicine, Qom University of Medical Sciences, Qom, Iran. , rfateh59@gmail.com
Abstract:   (2016 Views)
Background and Objectives: Efflux pumps are among the main mechanisms for antibiotic resistance in Escherichia coli (E.coli) strains. The present study aimed to investigate the relationship between 5 efflux pump genes; acrA, acrB, emrA, emrB, and mdtk and fluoroquinolone resistance in E.coli isolated from patients with urinary tract infections.
Methods: In this descriptive cross-sectional study, clinical samples were collected from several medical centers in Qom City, Iran, from June 2017 to September 2017. After the detection and primary identification of E.coli isolations using culture and biochemical tests, the antimicrobial susceptibility strains to the fluoroquinolones, such as Ciprofloxacin, Norfloxacin, Ofloxacin, and Levofloxacin were determined by disk diffusion method according to the Clinical and Laboratory Standards Institute (CLSI) guidelines. Identifying the genes encoding efflux pumps was performed in sensitive and resistant strains by Polymerase Chain Reaction (PCR) technique.
Results: Of the collected 170 clinical samples, 100 strains of E.coli were isolated and identified based on phenotypic characteristics. Evaluating antibiotic susceptibility of the strains demonstrated that 63(63%) isolates presented resistance to fluoroquinolones. PCR assay demonstrated that the prevalence of acr- AB, emrAB, and mdtk genes among fluoroquinolones resistant isolates were equal to 100%, 98%, and 94%, respectively. Furthermore, the frequency of the mentioned genes in fluoroquinolone-sensitive isolates was measured to be 34.2%, 27.02%, and 13.5%, respectively.
Conclusion: The present research results revealed that the presence of acrAB, emrAB, and mdtk efflux pumps genes is potentially a factor in resistance to fluoroquinolone antibiotics. The presence of these genes in sensitive strains may indicate that the genes are not transcribed or translated. According to the high resistance of E.coli strains to fluoroquinolone antibiotics, it is recommended that antibiotic susceptibility testing be performed before starting treatment.
Full-Text [PDF 1197 kb]   (693 Downloads)    
Type of Study: Original Article | Subject: میکروب شناسی
Received: 2020/12/7 | Accepted: 2021/05/17 | Published: 2021/05/31

References
1. Livermore DM. Current epidemiology and growing resistance of gram-negative pathogens. Korean J Intern Med. 2012; 27(2):128-42. [DOI:10.3904/kjim.2012.27.2.128] [PMID] [PMCID] [DOI:10.3904/kjim.2012.27.2.128]
2. Khalili MB, Sharifi Yazdi MK, Ebadi M, Sadeh M. [Correlation between urine analysis and urine culture in the diagnosis of urinary tract infection in Yazd central laboratory (Persian)]. Tehran Univ Med J. 2007; 65(9):53-8. http://tumj.tums.ac.ir/article-1-731-en.html
3. Binder S, Levitt AM, Sacks JJ, Hughes JM. Emerging infectious diseases: Public health issues for the 21st century. Science. 1999; 284(5418):1311-3. [DOI:10.1126/science.284.5418.1311] [PMID] [DOI:10.1126/science.284.5418.1311]
4. Yang J, Ye L, Wang W, Luo Y, Zhang Y, Han L. Diverse prevalence of 16S rRNA methylase genes armA and rmtB amongst clinical multidrug-resistant Escherichia coli and Klebsiella pneumoniae isolates. Int J Antimicrob Agents. 2011; 38(4):348-51. [DOI:10.1016/j.ijantimicag.2011.04.021] [PMID] [DOI:10.1016/j.ijantimicag.2011.04.021]
5. Van Bambeke F, Balzi E, Tulkens PM. Antibiotic efflux pumps. Biochem Pharmacol. 2000; 60(4):457-70. [DOI:10.1016/j.ijantimicag.2011.04.021] [PMID] [DOI:10.1016/j.ijantimicag.2011.04.021]
6. Lomovskaya O, Warren MS, Lee A, Galazzo J, Fronko R, Lee M, et al. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: Novel agents for combination therapy. Antimicrob Agents Chemother. 2001; 45(1):105-16. [DOI:10.1128/AAC.45.1.105-116.2001] [PMID] [PMCID] [DOI:10.1128/AAC.45.1.105-116.2001]
7. Sulavik MC, Houseweart C, Cramer C, Jiwani N, Murgolo N, Greene J, et al. Antibiotic susceptibility profiles ofescherichia coli strains lacking multidrug efflux pump genes. Antimicrob Agents Chemother. 2001; 45(4):1126-36.[DOI:10.1128/AAC.45.4.1126-1136.2001] [PMID] [PMCID] [DOI:10.1128/AAC.45.4.1126-1136.2001]
8. Patel JB, editor. Performance standards for antimicrobial susceptibility testing. Annapolis Junction, MD: Clinical and Laboratory Standards Institute; 2017. https://books.google.com/books?id=4Xq6swEACAAJ&dq
9. Doosti Mohajer M, Pajavand H, Abiri R, Alvandi A. [Phenotypic and genotypic efflux pumps in resistance to fluoroquinolones in E. coli isolated from inpatients in Kermanshah hospitals in 2013 (Persian)]. J Arak Univ Med Sci. 2017; 20(9):22-32. http://jams.arakmu.ac.ir/article-1-5024-fa.html
10. Gonzalez CM, Schaeffer AJ. Treatment of urinary tract infection: What's old, what's new, and what works. World J Urol. 1999; 17(6):372-82. [DOI:10.1007/s003450050163] [PMID] [DOI:10.1007/s003450050163]
11. Foxman B, Barlow R, D'arcy H, Gillespie B, Sobel JD. Candida vaginitis: Self‐reported incidence and associated costs.Sex Transm Dis. 2000; 27(4):230-5.[DOI:10.1097/00007435-200004000-00009] [PMID] [DOI:10.1097/00007435-200004000-00009]
12. Foxman B. Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs. Am J Med. 2002; 113(1 Suppl 1):5-13. [DOI:10.1016/S0002-9343(02)01054-9] [PMID] [DOI:10.1016/S0002-9343(02)01054-9]
13. Beyene G, Tsegaye W. Bacterial uropathogens in urinary tract infection and antibiotic susceptibility pattern in Jimma University specialized hospital, southwest Ethiopia. Ethiop J Health Sci. 2011; 21(2):141-6. [DOI:10.4314/ejhs.v21i2.69055] [PMID] [DOI:10.4314/ejhs.v21i2.69055]
14. Ronald AR, Nicolle LE, Stamm E, Krieger J, Warren J, Schaeffer A, et al. Urinary tract infection in adults: Research priorities and strategies. Int J Antimicrob Agents. 2001; 17(4):343-8.[DOI:10.1016/S0924-8579(01)00303-X] [PMID] [DOI:10.1016/S0924-8579(01)00303-X]
15. Kothari A, Sagar V. Antibiotic resistance in pathogens causing community-acquired urinary tract infections in India: A multicenter study. J Infect Dev Ctries. 2008; 2(05):354-8. [DOI:10.3855/jidc.196] [PMID] [DOI:10.3855/jidc.196]
16. Kahlmeter G, Menday P. Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO·SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections. J Antimicrob Chemother. 2003; 52(1):128-31.[DOI:10.1093/jac/dkg280] [PMID] [DOI:10.1093/jac/dkg280]
17. Mulder M, Kiefte-de Jong JC, Goessens WHF, de Visser H, Hofman A, Stricker BH, et al. Risk factors for resistance to ciprofloxacin in community-acquired urinary tract infections due to Escherichia coli in an elderly population. J Antimicrob Chemother. 2017; 72(1):281-9. [DOI:10.1093/jac/dkw399] [PMID] [DOI:10.1093/jac/dkw399]
18. Heidary M, Bahramian A, Goudarzi H, Eslami G, Hashemi A, Khoshnood S. [To study the association between AcrAB and Qep A efflux pumps and ciprofloxacin resistance among Escherichia coli and Klebsiella pneumoniae clinical strains (Persian)]. J Arak Uni Med Sci. 2016; 19(4):1-10. http://jams.arakmu.ac.ir/article-1-4155-en.html
19. Abdollahi Kheirabadi S, Najafipour S, Kafilzadeh F, Abdollahi A, Jafari S, Moravej A. [Evaluation of drug resistance pattern of escherichia coli strains isolated from Fasa Vali-e-Asr hospital patients (Persian)]. J Adv Biomed Sci. 2013; 2(4):273-8. http://jabs.fums.ac.ir/article-1-143-en.html
20. Mahdavi A, Nahaei MR, Akhi MT, Nahaei M, Dibavar MA. [Antibiotic resistance pattern against fluoroquinolones among escherichia coli isolated from ICU and out- patient clinic admitted patients with urinary tract infection (Persian)]. Med J Tabriz Univ Med Sci. 2009; 31(3):91-6. https://mj.tbzmed.ac.ir/Article/6273
21. Heidari-Soureshjani E, Heidari M, Doosti A. [Epidemiology of urinary tract infection and antibiotic resistance pattern of E. coli in patients referred to Imam Ali hospital in Farrokhshahr, Chaharmahal va Bakhtiari, Iran (Persian)]. J Shahrekord Univ Med Sci. 2013; 15(2):9-15. http://78.39.35.44/article-1-1272-fa.html
22. Johnson JR, Johnston B, Kuskowski MA, Sokurenko EV, Tchesnokova V. Intensity and mechanisms of fluoroquinolone resistance within the H30 and H30Rx subclones of Escherichia coli sequence type 131 compared with other fluoroquinolone-resistant E. coli. Antimicrob Agents Chemother. 2015; 59(8):4471-80. [DOI:10.1128/AAC.00673-15] [PMID] [PMCID] [DOI:10.1128/AAC.00673-15]
23. Korona-Glowniak I, Skrzypek K, Siwiec R, Wrobel A, Malm A. Fluoroquinolone-resistance mechanisms and phylogenetic background of clinical Escherichia coli strains isolated in south-east Poland. New Microbiol. 2016; 39(3):210-5. [PMID]
24. Sato T, Yokota SI, Uchida I, Okubo T, Usui M, Kusumoto M, et al. Fluoroquinolone resistance mechanisms in an Escherichia coli isolate, HUE1, without quinolone resistance-determining region mutations. Front Microbiol. 2013; 4:125.[DOI:10.3389/fmicb.2013.00125] [PMID] [PMCID] [DOI:10.3389/fmicb.2013.00125]
25. Yang Sh, Clayton SR, Zechiedrich EL. Relative contributions of the AcrAB, MdfA and NorE efflux pumps to quinolone resistance in Escherichia coli. J Antimicrob Chemother. 2003; 51(3):545-56. [DOI:10.1093/jac/dkg126] [PMID] [DOI:10.1093/jac/dkg126]
26. Helaly GF, Shawky Sh, Amer R, Kader OA, El-Sawaf G, El Kholy MA. Expression of AcrAB efflux pump and role of mefloquine as efflux pump inhibitor in MDR E. coli. Am J Infect Dis Microbiol. 2016; 4(1):6-13. http://www.sciepub.com/AJIDM/abstract/5652
27. Swick MC, Morgan-Linnell SK, Carlson KM, Zechiedrich L. Expression of multidrug efflux pump genes acrAB-tolC, mdfA, and norE in Escherichia coli clinical isolates as a function of fluoroquinolone and multidrug resistance. Antimicrob Agents Chemother. 2011; 55(2):921-4. [DOI:10.1128/AAC.00996-10] [PMID] [PMCID] [DOI:10.1128/AAC.00996-10]
28. Nordmann P, Poirel L. Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae. J Antimicrob Chemother. 2005; 56(3):463-9. [DOI:10.1093/jac/dki245] [PMID] [DOI:10.1093/jac/dki245]
29. Andres P, Lucero C, Soler-Bistué A, Guerriero L, Albornoz E, Tran T, et al. Differential distribution of plasmid-mediated quinolone resistance genes in clinical enterobacteria with unusual phenotypes of quinolone susceptibility from Argentina. Antimicrob Agents Chemother. 2013; 57(6):2467-75.[DOI:10.1128/AAC.01615-12] [PMID] [PMCID] [DOI:10.1128/AAC.01615-12]
30. Akya A, Chegenelorestani R, Elahi A. [Effect of AcrAB efflux pump on ciprofloxacin resistance rate in Escherichia coli isolates (Persian)]. Qom Univ Med Sci J. 2018; 11(12):1-9. http://journal.muq.ac.ir/article-1-1214-en.html [DOI:10.29252/qums.12.11.5]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Qom University of Medical Sciences Journal

Designed & Developed by : Yektaweb